European Archives - Page 10 of 1043 - European Medical Journal

Chest CT Myosteatosis Markers Improve Lung Cancer Survival Predictions

Preoperative myosteatosis markers linked to worse survival in early-stage lung cancer patients, improving risk stratification.

A New Approach to Hypertension: EUS-RFA Shows Promise for Primary Aldosteronism

Minimally invasive endoscopic ultrasound-guided radiofrequency ablation offers a safe and effective alternative to adrenalectomy for treating unilateral aldosterone-producing adenomas.

Nonselective β-Blocker Use Linked to Mortality After Stem Cell Transplantation

Nonselective β-blockers may impair haematopoietic regeneration after transplantation, particularly with post-transplant chemotherapy.

Diabetes Medications May Reduce COPD Exacerbation Risk, Study Finds

SGLT-2is and GLP-1RAs linked to lower COPD exacerbation risk in T2D patients, study finds.

Navigating Antimicrobial Resistance: Interview with Timothy Walsh

We discovered NDM-1, which stands for New Delhi metallo-beta-lactamase, at the end of 2009, but nobody cared about it too much at the time…

Single-Cell Study Reveals How the Immune System Evolves from Birth to Old Age

New research maps immune system changes across the human lifespan, revealing key insights into aging and health.

New Model Improves Early Detection of Lymph Node Metastasis in Breast Cancer

New model enhances early detection of lymph node metastasis in breast cancer using CEUS images and machine learning.

Air Pollution Exposure Linked to Liver Inflammation and Fatty Liver Disease

Even low levels of air pollution can cause liver inflammation, fibrosis, and metabolic changes linked to fatty liver disease.

Salt Substitute Cuts Stroke Risk and Mortality in Major Clinical Trial

Replacing regular salt with a reduced-sodium, added-potassium substitute significantly lowered recurrent stroke and mortality risk in stroke patients.

Avacopan Shows Promise for ANCA-Associated Vasculitis Despite High Discontinuation Rates

A new Japanese retrospective study confirms that avacopan can effectively induce and sustain remission in patients with ANCA-associated vasculitis, reducing the need for glucocorticoids.